ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,475Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 278

$589K Total Retail Price of All Prescriptions

Rank: 81 out of 278

421 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 421 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 421 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 7,042 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
SIMVASTATIN 466 374 1 4
AMLODIPINE BESYLATE 341 273 2 7
OMEPRAZOLE 278 207 3 3
LEVOTHYROXINE SODIUM 262 218 4 2
FUROSEMIDE 245 198 5 6
LISINOPRIL 242 177 6 5
METOPROLOL TARTRATE 195 148 7 9
ATENOLOL 172 152 8 18
HYDROCODONE-ACETAMINOPHEN 162 104 S3 9 1
DONEPEZIL HCL 153 138 10 29
HYDROCHLOROTHIAZIDE 146 112 11 15
CRESTOR 144 81 12 19
WARFARIN SODIUM 142 119 13 11
GABAPENTIN 140 93 14 12
METFORMIN HCL 137 60 15 8
SERTRALINE HCL 121 96 16 25
CITALOPRAM HBR 121 102 16 21
AZITHROMYCIN 118 81 18 39
POTASSIUM CHLORIDE 113 104 19 17
METOPROLOL SUCCINATE 111 90 20 10
PROAIR HFA 109 58 21 34
SPIRIVA 105 83 22 49
NEXIUM 101 69 23 14
ATORVASTATIN CALCIUM 96 85 24 13
CLOPIDOGREL 95 71 25 20
ADVAIR DISKUS 85 59 26 45
LOSARTAN POTASSIUM 82 70 27 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 60 27 31
PRAVASTATIN SODIUM 80 67 29 16
CARVEDILOL 79 67 30 23
PREDNISONE 78 63 31 35
ISOSORBIDE MONONITRATE ER 77 59 32 33
NAMENDA 77 70 32 48
GLIMEPIRIDE 77 45 32 28
FENTANYL 72 59 S2 35 82
CLONIDINE HCL 70 59 36 50
ZOLPIDEM TARTRATE 69 42 37 26
ALLOPURINOL 68 45 38 38
PLAVIX 67 47 39 30
TAMSULOSIN HCL 63 51 40 32
TRIAMTERENE-HCTZ 62 53 41 58
CIPROFLOXACIN HCL 61 49 42 65
SPIRONOLACTONE 61 47 42 62
MIRTAZAPINE 57 38 44 61
BENAZEPRIL HCL 57 55 44 108
PANTOPRAZOLE SODIUM 56 28 46 36
LOVASTATIN 54 54 47 52
ESCITALOPRAM OXALATE 54 38 47 63
BACLOFEN 52 12 49 172
OXYCODONE-ACETAMINOPHEN 50 32 S2 50 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.